The EU Clinical Trials Register (EU-CTR) has been formally recognised by the World Health Organization (WHO) as one of the primary registries for its International Clinical Trials Registry Platform (ICTRP).
The Outsourcing-pharma.com team is heading to Boston, Massachusetts for Patient Recruitment Outsourcing – our exciting new US conference and networking event.
Medical Photography is a potentially valuable yet underused resource in clinical trials according to Illingworth Research, which aims to increase its exposure with a new service.
Contract manufacturing organisation (CMO) Aurobindo Pharma has teamed up with Russian supplement maker OJSC Diod to establish a manufacturing joint-venture.
in-Pharma Technologist brings you its round-up of the new appointments within the pharmaceutical industry, including news from Merck KGaA, Sanofi Pasteur, H&P and CADTH.
The growth seen in the early-phase contract development sector earlier this year may have stalled as pharmaceutical industry sponsors continue to hold off on expensive toxicology studies, according to new analysis.
In-PharmaTechnologist presents its latest round-up of executive moves in the pharma industry, including appointments at Akrimax, Vernalis, Sanofi and Pregis.
An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.
Synteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector.
UK-based contract manufacturing organisation (CMO) SCM Pharma has struck a deal with urology experts Speciality European Pharma (SEP) to help bring SEP's oncology product, Plenaxis, to the European market.
Marketing applications should contain details of clinical trial ethics and be rejected if serious violations are found, said some EMA workshop participants.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new role for former Genzyme CEO and a leadership change at Astellas Europe.
A new, tougher approvals policy for pharmaceutical products in China will bring opportunities for Western contract companies able to help domestic firms meet the strict new rules, according to a seminar at InterPhex in New York.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Cytel and Laureate Biopharmaceutical.
Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.
GSK and Teva will invest in Russian drug manufacturing in response to PM Vladimir Putin’s warning that Pharmas will face restrictions if they fail to boost local production and transfer technology.
A report claims that extended clinical trial data exclusivity would benefit pharmaceutical innovation, leading to over 200 extra drug approvals and to greater life expectancy in future decades.
Creation of a “one-stop shop” for health research approval would free the UK from overly burdensome regulations that are stifling innovation, according to a report.
Outsourcing-Pharma presents a round up five of our top articles on strategic partnering, which continued apace in 2010, including deals by Covance, PPD and Parexel.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Quintiles, ACM and Premier Research.
Contract service providers continued to move into new geographies in search of more efficient R&D and production in 2010. Here we present five of our most popular articles on the topic, including Pfizer in Asia and the BRIC wall.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new chairman at PhRMA and appointments at McKesson, Elan and GeoVax.
Drafting ICH M7 guidance on genotoxic impurities will require a lot of work from industry and regulators but has the potential to resolve a number of issues.
WikiLeaks has published a list of overseas biopharmaceutical facilities considered vital to US national security as part of its release of leaked diplomatic cables.
Kerri Weingard, research director for Accumed, says the growing numbers of patients enrolling in multiple clinical trials are threatening the integrity of the clinical development process.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Premier Research, Porsolt and BioStorage.
IMS Health predicts China will become the world’s second largest pharmaceutical market by 2015 due to robust economic growth and healthcare reforms that allow for increased spending on drugs.
PPD signs clinical imaging and formulation development collaborations, reorganises reporting units and cites “improved performance in emerging markets” and spending controls as key to third quarter gains.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at AMRI, Novella Clinical, BioClinica and Idis.
